In a study of 36 individuals recovering from mild to severe COVID-19, all had SARS-CoV-2–specific CD4+ and CD8+ T cells that recognized multiple regions of the SARS-CoV-2 nucleocapsid (N) protein (92). The gene discussed is CD8A; the disease is COVID-19.